How should I taper prednisone 40 mg over a six‑week period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prednisone 40 mg Taper Over Six Weeks

Taper prednisone 40 mg gradually by reducing the dose in small increments (5-10 mg decrements) every 1-2 weeks, monitoring closely for withdrawal symptoms, with the understanding that you may need to slow the taper significantly once you reach lower doses (below 10 mg). 1

Practical Tapering Algorithm

The FDA labeling emphasizes that dosage requirements must be individualized based on disease response and patient tolerance, but provides clear guidance that withdrawal should be gradual rather than abrupt 1. Here's a structured approach:

Weeks 1-2: 40 mg → 30 mg

  • Start at 40 mg daily, taken in the morning before 9 AM 1
  • Reduce by 10 mg after 1-2 weeks if disease is controlled
  • Take with food to minimize gastric irritation 1

Weeks 3-4: 30 mg → 20 mg

  • Continue 10 mg decrements every 1-2 weeks
  • At these supraphysiologic doses, you're primarily managing the underlying disease, not adrenal suppression 2

Weeks 5-6: 20 mg → 10 mg

  • Reduce by 5-10 mg
  • Critical zone begins: Glucocorticoid withdrawal syndrome becomes more likely as you approach physiological doses 2

Key Considerations for Safe Tapering

Glucocorticoid Withdrawal Syndrome

Expect withdrawal symptoms in up to 50% of patients, including myalgias, weakness, fatigue, sleep disturbances, and mood changes 2. These symptoms:

  • Occur due to abrupt decreases in glucocorticoid exposure causing inflammatory cytokine increases
  • Overlap significantly with adrenal insufficiency symptoms
  • Are more likely with higher initial doses, longer treatment duration, and presence of Cushingoid features 2

If severe withdrawal symptoms occur: Temporarily increase the dose back to the most recent tolerated level, then resume tapering more slowly 2. The 2024 European Society of Endocrinology/Endocrine Society joint guideline specifically recommends extending the taper duration when withdrawal is problematic 2.

When to Slow Down Further

Once you reach doses below 10 mg (approaching the physiological range of 5-7.5 mg prednisone equivalent), you must taper much more slowly 2. Recent 2026 evidence shows that each 1 mg reduction at physiological doses produces measurable HPA axis recovery, with reductions >2 mg producing larger cortisol increases than 1 mg reductions 3. This means:

  • Below 10 mg: Consider 2.5 mg decrements every 2-4 weeks
  • Below 5 mg: Consider 1 mg decrements every 2-4 weeks
  • Final doses may need to be as small as 1 mg or less before complete cessation 3

Disease-Specific Context Matters

The evidence shows significant variation by condition:

  • Acute asthma: No benefit to tapering after 10 days of 40 mg daily—abrupt cessation is safe 4, 5
  • Myasthenia gravis: Rapid tapering (earlier and faster decrease) with azathioprine showed better outcomes than slow tapering 6
  • Autoimmune hepatitis: Slow tapering (≥3 weeks to get below 20 mg) significantly reduced adverse events compared to rapid tapering 7
  • Polymyalgia rheumatica: Slow tapering from low initial doses minimizes relapse risk 8

Without knowing your specific condition, err on the side of slower tapering to minimize withdrawal symptoms and disease flare risk.

Critical Pitfalls to Avoid

  1. Don't test adrenal function while on supraphysiologic doses: At 40 mg, HPA axis suppression is expected and testing is unnecessary 2. Only consider testing once you're tapering below physiological doses (5-7.5 mg) and planning complete discontinuation.

  2. Watch for concomitant nephrotoxic medications: Exposure to proton pump inhibitors or trimethoprim-sulfamethoxazole during tapering can prolong recovery time 9.

  3. Don't assume low morning cortisol means you can't stop: Recent evidence shows 42% of patients who successfully discontinued prednisone had nadir morning cortisol <150 nmol/L, including some <28 nmol/L 3. Physiological dose tapering itself enables HPA axis recovery.

  4. Recognize that six weeks may not be enough: For patients on long-term therapy with Cushingoid features, a truly tolerable taper may require many months 2, 3. The six-week timeframe works for getting from 40 mg to approximately 10 mg, but complete discontinuation often requires longer.

Monitoring Strategy

  • Weekly check-ins during the first 2-3 weeks to assess disease control
  • Every 1-2 weeks thereafter to monitor for withdrawal symptoms
  • Slow the taper immediately if withdrawal symptoms emerge—don't push through them 2
  • Consider adding steroid-sparing agents if prolonged therapy is anticipated 8

The FDA labeling is explicit: "constant monitoring is needed in regard to drug dosage" and adjustments should be made based on clinical status, individual drug responsiveness, and stressful situations 1.

Related Questions

Should I skip day 4 (or days 4‑5) of my prednisone course and start tapering, and can I move the entire daily dose to earlier in the day (e.g., two doses in the morning and at lunchtime) to avoid insomnia while treating a painful rash?
What is an appropriate prednisone taper for a patient who has been on 40 mg daily for 14 days and wishes to reduce to 30 mg for 2 weeks, then 25 mg for 2 weeks, then 20 mg for 2 weeks, continuing down to 5 mg daily for 2 weeks?
What is the recommended tapering schedule for prednisone in a patient who has been on high-dose therapy (≥40 mg per day)?
Can you help me create a tapering schedule for prednisone for a patient?
At what daily dose and duration of prednisone (or equivalent) should a steroid taper be initiated?
What is the most likely diagnosis in a patient with hypotension, elevated high‑sensitivity troponin I, normal 2‑D echocardiogram, AST > ALT, severe metabolic acidosis, and acute kidney injury?
In a young adult with anxiety who is taking sertraline and alprazolam, does smoking, vaping, or using Juul nicotine products cause a dangerous increase in blood pressure?
Is Imdur (isosorbide mononitrate) a short‑acting nitrate?
Should low vitamin B12 be replaced when folate levels are normal?
Can digoxin be administered to a patient with hypotension?
In a 79-year-old patient with moderate obstructive sleep apnea and a high periodic limb movement index, can continuous positive airway pressure (CPAP) therapy eliminate the periodic limb movements in sleep (PLMS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.